NDC 0068-0599

Rifadin IV NOVAPLUS

Rifampin

Rifadin IV NOVAPLUS is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Rifampin.

Product ID0068-0599_0b052072-4d59-4847-adc9-0c9b56f11f2c
NDC0068-0599
Product TypeHuman Prescription Drug
Proprietary NameRifadin IV NOVAPLUS
Generic NameRifampin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2017-02-01
Marketing CategoryNDA / NDA
Application NumberNDA050627
Labeler NameSanofi-Aventis U.S. LLC
Substance NameRIFAMPIN
Active Ingredient Strength600 mg/10mL
Pharm ClassesRifamycin Antibacterial [EPC],Rifamycins [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0068-0599-01

1 VIAL, GLASS in 1 CARTON (0068-0599-01) > 10 mL in 1 VIAL, GLASS
Marketing Start Date2017-02-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0068-0599-10 [00068059910]

Rifadin IV NOVAPLUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA050627
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-02-01
Marketing End Date2019-09-05

NDC 0068-0599-01 [00068059901]

Rifadin IV NOVAPLUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA050627
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-02-01

Drug Details

Active Ingredients

IngredientStrength
RIFAMPIN600 mg/10mL

OpenFDA Data

SPL SET ID:87839f65-cb33-412e-929e-564136501a84
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 207436
  • 312821
  • Pharmacological Class

    • Rifamycin Antibacterial [EPC]
    • Rifamycins [CS]

    NDC Crossover Matching brand name "Rifadin IV NOVAPLUS" or generic name "Rifampin"

    NDCBrand NameGeneric Name
    0068-0599Rifadin IV NOVAPLUSrifampin
    0068-0508Rifadinrifampin
    0068-0510Rifadinrifampin
    0068-0597Rifadin IVrifampin
    0143-9230RifampinRifampin
    0185-0799RifampinRifampin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.